← Oncology Approval Tracker

FDA DECISION ·

Opdivo + Yervoy

nivolumab + ipilimumab · Bristol Myers Squibb

FDA approvalNew or expanded indicationMalignant pleural mesothelioma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First-line treatment for adults with unresectable malignant pleural mesothelioma.

LAMPGEN ANALYSIS

Why it matters

Established dual checkpoint blockade as a first-line treatment option in this disease.

What research teams should watch

Document histology and resectability and plan management for lung symptoms that may reflect disease or immune toxicity.

PRIMARY RECORDS

Sources